Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 13Thoracic 5Other hematologic neoplasm 5Genitourinary 5Gastrointestinal 5Head & Neck 4Tumor-Agnostic 3Lymphoid 3CNS 3Sarcoma 2Gynecologic 2Plasma cell 1Classical hematology 1

Conditions

Neoplasms 3

Interventions

pembrolizumab 95Paclitaxel 86Gemcitabine 84Carboplatin 79Surveys and Questionnaires 72Docetaxel 61Bevacizumab 61Nivolumab 59Cisplatin 59Magnetic Resonance Spectroscopy 50Blood Specimen Collection 50Fluorouracil 48Radiotherapy 47Capecitabine 47Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 38Biopsy 36atezolizumab 35Leucovorin 35Pemetrexed 34Standard of Care 32Cetuximab 32Specimen Handling 31Trastuzumab 30Radiosurgery 29Ipilimumab 28Cyclophosphamide 28Interviews as Topic 27olaparib 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Physical Therapy Modalities × Tumor-Agnostic × Clear all
NCT06170385 2026-02-06

PEACE

University of Alberta

Phase NA Completed
10 enrolled
Tumor-Agnostic

Neoplasms

NCT04930406 2024-02-20

Impact of Physical Therapy Intervention on Foot and Ankle Function

Children's Hospitals and Clinics of Minnesota

Unknown
80 enrolled
Tumor-Agnostic

Neoplasms

NCT02306252 2017-09-12

CARE Program

UNC Lineberger Comprehensive Cancer Center

Phase NA Completed
67 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡